Skip to main content
. 2013 Apr 10;172(2):290–299. doi: 10.1111/cei.12049

Fig. 4.

Fig. 4

In-vivo application of hydrocortisone (100 mg); (a) plasma cortisol levels, (b) individual responses to delayed-type hypersensitivity (DTH)-resembling in-vitro test, logarithmic scale; *P < 0·05; one-way repeated-measures (RM) analysis of variance (anova) followed by Fisher's least significant difference (LSD) test.